Navigation Links
VIRxSYS to Host a Web Conference to Announce Clinical Trial Update
Date:7/21/2008

Summary of data from five 2008 conferences

GAITHERSBURG, Md., July 21 /PRNewswire/ -- VIRxSYS Corporation, a privately held company developing gene therapies for HIV and genetic diseases, will present an update on the VRX496 Phase I and Phase II clinical trials for the media and members of the advocacy community. VRX496 is an investigational gene therapy for the treatment of AIDS. The presentation will take place on Thursday, July 24, 2008 at 11 a.m. EDT. The presentation can be accessed through a secure web site, https://www.livemeeting.com/cc/vcc/join?id=w5395452&role=attend&pw=A539545 and toll-free conference line: (800) 768-6570, using the passcode 5395452.

The speakers will be:

-- Gary McGarrity, PhD, Executive Vice President for Scientific Affairs, VIRxSYS

-- Carl June, MD, Professor, Department of Pathology and Laboratory Medicine, University of Pennsylvania

"Over the last six months we have presented clinical trial update for VRX496 and preclinical development update for VRX1023 at five conferences in three countries. We wanted to take this opportunity to summarize what we have shown over the last six months as well as talk about what we have learned at the conferences regarding how VRX496 and VRX1023 might play in the treatment of HIV infection," said Riku Rautsola, PhD, President and CEO of VIRxSYS. "These conferences have not just been an opportunity to present our data, but we have also learned more about what we do and gotten feedback from leaders in the field. For example, in Paris, Dr. Fauci's presentation focused on the discovery and identification of a new immune cell receptor that binds to HIV, a cell adhesion molecule known as integrin alpha 4 beta 7 that is found to direct CD4 T cell traffic to GALT and enhance cellular interaction through forming synapses between T cells. This was interesti
'/>"/>

SOURCE VIRxSYS Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. VIRxSYS Presents Data on HIV Vaccine at Keystone HIV Vaccine Symposia
2. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
3. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
4. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
5. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
6. ViroPharma to Present at Three Upcoming Healthcare Conferences
7. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
8. Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO)
9. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
10. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
11. Promising Data from Paratek Pharmaceuticals MAR Inhibitor Program Presented in Late Breaker Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 2014 According to the ... (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave), Application (General ... Global Forecasts to 2019", published by MarketsandMarkets, studies the ... of 2014 to 2019. The market is expected ... of 9.6% from 2014 to 2019. ...
(Date:9/23/2014)... Ill. , Sept. 23, 2014  Medela announced ... Atlanta Biomedical Company (ABC), assigning Medela as the exclusive ... now known as the Medela Enteral Feeding Pump. Through ... to help NICU parents and healthcare professionals by offering ... The Medela Enteral Feeding Pump is integral to the ...
(Date:9/23/2014)... , Sept. 23, 2014 A case report ... a SynCardia temporary Total Artificial Heart into a patient ... ventricles were reversed, along with other abnormalities. ... modifying the SynCardia Total Artificial Heart to treat a ... report and video in the Journal of Visualized Experiments ...
Breaking Medicine Technology:Ablation Technologies Market Worth $3.81 Billion by 2019 2Ablation Technologies Market Worth $3.81 Billion by 2019 3Ablation Technologies Market Worth $3.81 Billion by 2019 4Medela Enters Exclusive Enteral Feeding Pump Agreement with Atlanta Biomedical Company 21st Use of the SynCardia Total Artificial Heart in a 17-Year-Old Congenital Heart Disease Patient at Pediatric Hospital 21st Use of the SynCardia Total Artificial Heart in a 17-Year-Old Congenital Heart Disease Patient at Pediatric Hospital 31st Use of the SynCardia Total Artificial Heart in a 17-Year-Old Congenital Heart Disease Patient at Pediatric Hospital 4
... 10, 2011 In the year since a devastating earthquake ... and around the world have launched and supported projects to ... the New Year began, Rotary clubs started a $200,000 initiative ... outbreak of the waterborne disease. Rotary clubs worldwide ...
... Jan. 10, 2011 CoreLab Partners, Inc , ... Inc and Medifacts International, has launched a new advanced ... are pleased to announce the release of our proprietary ... development continuum by offering sponsors advanced technologies and integrated ...
Cached Medicine Technology:Rotary Clubs Remain Committed to Rebuilding Quake-Ravaged Haiti 2Rotary Clubs Remain Committed to Rebuilding Quake-Ravaged Haiti 3CoreLab Partners Launches Advanced Imaging Application 2CoreLab Partners Launches Advanced Imaging Application 3
(Date:9/23/2014)... (PRWEB) September 23, 2014 What ... The National Quality Forum (NQF) released a ... http://www.qualityforum.org/WorkArea/linkit.aspx?LinkIdentifier=id&ItemID=77687 ), and an infographic ( http://bit.ly/1tX3lzA ) ... cost of healthcare, how patients define affordability, and ... to get the best possible healthcare at the ...
(Date:9/23/2014)... NY (PRWEB) September 23, 2014 ... on Manhattan’s Upper West Side that embodies the ... Inhabiting Eden: Christians, Scripture and the Ecological Crisis, ... A. B. Rhodes Professor Emerita of Old Testament ... Bible for ancient wisdom that lends insight into ...
(Date:9/23/2014)... Sept. 23, 2014 (HealthDay News) -- The number ... prescription drugs is growing, so doctors need to ... and Drug Administration warned Tuesday. In a ... widespread that it has launched a program to ... administrators about proper drug purchasing procedures. The program ...
(Date:9/23/2014)... are already obese as teenagers could grow up to ... of normal weight. So says Petter Lundborg of Lund ... of Linneas University and Lund University, all in Sweden. ... Kingdom and the United States, and the results are ... The researchers analyzed large-scale data of 145,193 Swedish-born brothers ...
(Date:9/23/2014)... Both patients and healthcare professionals believe diagnosis of ... greatly outweighs the potential disadvantages of subsequent radiologic ... according to a new study published in the ... , Diagnostic tests used for cancer screening programs ... for colorectal cancer with CT colonography, abdominal and ...
Breaking Medicine News(10 mins):Health News:Finding Affordable Care: Asking the Right Question is Key 2Health News:Inhabiting Eden: Christians, Scripture, and the Ecological Crisis – Public Lecture to Discuss Faith-Based Environmentalism 2Health News:Note to young men: Fat doesn't pay 2Health News:Patients accept false-positives to achieve diagnostic sensitivity 2Health News:Patients accept false-positives to achieve diagnostic sensitivity 3
... of New Molecular Entities Drops to Historic Low ... Face Increasing Competition from ... Scientific business of Thomson,Reuters today announced the availability ... Factbook, an indispensable reference,and business planning tool for ...
... welcome to out-of-state intended parents, SAN RAMON, ... decision to allow gay couples to marry strengthens ... Bay Area (RSC), one of,the state,s leading fertility ... "California,s legalization of same-sex marriage supports RSC,s,long-held ...
... for Immigration and Naturalization ready at Passport ... ... New vaccine requirements will affect,anyone who is applying for an ... status for permanent residence. Applicants,must show proof of vaccinations against vaccine-preventable ...
... Excessive IMP-3, not found in harmless moles, may be key ... produces high levels of a protein called IMP-3, which is ... researchers report. , They said the finding may offer doctors ... type of skin cancer -- from benign moles that look ...
... The American Heart,Association announces the call for ... association,s highest honor for health and science,reporting., ... and honor the career,achievements of science, health and ... in the fight against heart disease and,stroke. This ...
... County,Place Matters Team will host a three-day meeting July ... that lead to poor health outcomes,in individuals from low-income ... cities and counties will attend. Place Matters,is a national ... Health Policy Institute and is funded by the W. ...
Cached Medicine News:Health News:Thomson Reuters Publishes CMR International's 2008 Pharmaceutical R&D Factbook, Now Available for the First Time Online 2Health News:California Supreme Court Gay-Marriage Ruling Reinforces Top Bay Area Fertility Specialists' Support for Same-Sex Couples 2Health News:USCIS Tightens Vaccination Requirements 2Health News:Protein Gives Doctors New Tool to Detect Melanoma 2Health News:Alameda County Hosts National Initiative to Reduce Health Disparities 2
... Retinol binding Proetin (RBP) is small ... a complex with pre-albumin in blood but ... has been deliverd to the target cells. ... at the glomerulus and catabolized in the,renal ...
... is an enzyme immunoassay (EIA) kit for ... of the subclass of Anti-Neutrophil Cytoplasmic Antibodies ... as an aid in the diagnosis of ... associated with vasculitic disorders and glomerulonephritis (GN). ...
Anti-MPO ANCA EIA Auto-Immune Markers 013-MPO-96 Myeloperoxidase...
GBM -Ab EIA Auto-Immune Markers 013-GBM-96 Glomerular Basement Membrane...
Medicine Products: